ValleyDAO is a decentralized platform revolutionizing funding and translation for synthetic biology research to combat climate change. By empowering a global community with tokenized IP frameworks, we drive impactful biotech innovations from labs to market, fostering real-world climate solutions minus the greenwashing.
Curation
Fundraising
AMM
Predicted global temperature increase by end of this century
Majority of synthetic biology funding flows to health, leaving climate application funding only at 20%
Synthetic biology market potential by 2030 for non-medicine applications
Synthetic biology has the potential to revolutionize sustainable production across food, energy, chemicals, and materials, paving the way for a future of material abundance that benefits both people and the planet.
Synthetic biology is revolutionizing our ability to engineer life, enabling the design of microorganisms and plants to address global challenges such as CO2 pollution, sustainable food production, and environmental clean-up. ...
Leverage synthetic biology and metabolic engineering to produce sustainable materials, fuels, and chemicals. Key technologies include microbial cell factories, enzyme optimization, and precision fermentation, enabling scalable and eco-friendly alternatives to traditional manufacturing.
Engineer microbes and enzymes to remove pollutants and degrade plastics, recover critical resources like metals, and restore ecosystems. Key technologies include bioleaching, pollutant-degrading enzymes, and microbial consortia.
Transform farming and food systems with engineered crops, microbiomes, and alternative proteins. Key technologies include precision gene editing (CRISPR), soil microbiome engineering, and cellular agriculture, ensuring sustainable, resilient, and nutritious food production.
ValleyDAO captures value through funding and translating synthetic biology research into impactful solutions. By securing exclusive or sublicensable rights to IP generated through funded projects, ValleyDAO monetizes this IP via two primary pathways:...
Synbiobeta
Forbes
Molecule